Reduced sputum expression of interferon-stimulated genes in severe COPD

Clarissa Hilzendeger,1 Jane da Silva,2 Monique Henket,1 Florence Schleich,1 Jean Louis Corhay,1 Tatiana Kebadze,3 Michael R Edwards,3 Patrick Mallia,3 Sebastian L Johnston,3 Renaud Louis1 1Department of Respiratory Medicine, Centre Hospitalier Universitaire (CHU) Liege, Groupe Interdisciplinaire de...

Full description

Bibliographic Details
Main Authors: Hilzendeger C, da Silva J, Henket M, Schleich F, Corhay JL, Kebadze T, Edwards MR, Mallia P, Johnston SL, Louis R
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/reduced-sputum-expression-of-interferon-stimulated-genes-in-severe-cop-peer-reviewed-article-COPD
_version_ 1818482934453108736
author Hilzendeger C
da Silva J
Henket M
Schleich F
Corhay JL
Kebadze T
Edwards MR
Mallia P
Johnston SL
Louis R
author_facet Hilzendeger C
da Silva J
Henket M
Schleich F
Corhay JL
Kebadze T
Edwards MR
Mallia P
Johnston SL
Louis R
author_sort Hilzendeger C
collection DOAJ
description Clarissa Hilzendeger,1 Jane da Silva,2 Monique Henket,1 Florence Schleich,1 Jean Louis Corhay,1 Tatiana Kebadze,3 Michael R Edwards,3 Patrick Mallia,3 Sebastian L Johnston,3 Renaud Louis1 1Department of Respiratory Medicine, Centre Hospitalier Universitaire (CHU) Liege, Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA) I3 University of Liege, Belgium; 2Department of Medicine, Post-graduate Program in Health Sciences, University of Southern Santa Catarina, Palhoça-SC, Brazil; 3Airway Disease Division, Airway Disease Infection Section, National Heart and Lung Institute, Imperial College, London, UK Background: Exacerbations of COPD are frequent and commonly triggered by respiratory tract infections. The purpose of our study was to investigate innate immunity in stable COPD patients.Methods: Induced sputum was collected from 51 stable consecutive COPD patients recruited from the COPD Clinic of CHU Liege and 35 healthy subjects. Expression of interferons beta (IFN-β) and lambda1 (IL-29), IFN-stimulated genes (ISGs) MxA, OAS, and viperin were measured in total sputum cells by reverse transcription quantitative polymerase chain reaction (RT-qPCR). The presence of Picornaviruses was assessed by RT-PCR, while potential pathogenic microorganisms (PPM) were identified by sputum bacteriology.Results: Expression of IL-29 was found in 16 of 51 COPD patients (31%) and in nine of 35 healthy subjects (26%), while IFN-β was detected in six of 51 COPD patients (12%) and in two of 35 healthy subjects (6%). ISGs were easily detectable in both groups. In the whole group of COPD patients, OAS expression was decreased (P<0.05), while that of viperin was increased (P<0.01) compared to healthy subjects. No difference was found with respect to MxA. COPD patients from group D of Global Initiative for Chronic Obstructive Lung Disease (GOLD) had reduced expression of all three ISGs (P<0.01 for MxA, P<0.05 for OAS, and P<0.01 for viperin) as compared to those of group B patients. Picornaviruses were detected in eight of 51 (16%) COPD patients vs four of 33 (12%) healthy subjects, while PPM were detected in seven of 39 (18%) COPD patients and associated with raised sputum neutrophil counts. IFN-β expression was raised when either picornavirus or PPM were detected (P=0.06), but no difference was seen regarding IL-29 or ISGs.Conclusion: ISGs expression was reduced in severe COPD that may favor exacerbation and contribute to disease progress by altering response to infection. Keywords: COPD, innate immunity, interferon-β, interferon-λ1, interferon-stimulated genes
first_indexed 2024-12-10T11:53:31Z
format Article
id doaj.art-271995afd2b44aca88fefeef99783d66
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-12-10T11:53:31Z
publishDate 2016-06-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-271995afd2b44aca88fefeef99783d662022-12-22T01:49:51ZengDove Medical PressInternational Journal of COPD1178-20052016-06-012016Issue 11485149427703Reduced sputum expression of interferon-stimulated genes in severe COPDHilzendeger Cda Silva JHenket MSchleich FCorhay JLKebadze TEdwards MRMallia PJohnston SLLouis RClarissa Hilzendeger,1 Jane da Silva,2 Monique Henket,1 Florence Schleich,1 Jean Louis Corhay,1 Tatiana Kebadze,3 Michael R Edwards,3 Patrick Mallia,3 Sebastian L Johnston,3 Renaud Louis1 1Department of Respiratory Medicine, Centre Hospitalier Universitaire (CHU) Liege, Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA) I3 University of Liege, Belgium; 2Department of Medicine, Post-graduate Program in Health Sciences, University of Southern Santa Catarina, Palhoça-SC, Brazil; 3Airway Disease Division, Airway Disease Infection Section, National Heart and Lung Institute, Imperial College, London, UK Background: Exacerbations of COPD are frequent and commonly triggered by respiratory tract infections. The purpose of our study was to investigate innate immunity in stable COPD patients.Methods: Induced sputum was collected from 51 stable consecutive COPD patients recruited from the COPD Clinic of CHU Liege and 35 healthy subjects. Expression of interferons beta (IFN-β) and lambda1 (IL-29), IFN-stimulated genes (ISGs) MxA, OAS, and viperin were measured in total sputum cells by reverse transcription quantitative polymerase chain reaction (RT-qPCR). The presence of Picornaviruses was assessed by RT-PCR, while potential pathogenic microorganisms (PPM) were identified by sputum bacteriology.Results: Expression of IL-29 was found in 16 of 51 COPD patients (31%) and in nine of 35 healthy subjects (26%), while IFN-β was detected in six of 51 COPD patients (12%) and in two of 35 healthy subjects (6%). ISGs were easily detectable in both groups. In the whole group of COPD patients, OAS expression was decreased (P<0.05), while that of viperin was increased (P<0.01) compared to healthy subjects. No difference was found with respect to MxA. COPD patients from group D of Global Initiative for Chronic Obstructive Lung Disease (GOLD) had reduced expression of all three ISGs (P<0.01 for MxA, P<0.05 for OAS, and P<0.01 for viperin) as compared to those of group B patients. Picornaviruses were detected in eight of 51 (16%) COPD patients vs four of 33 (12%) healthy subjects, while PPM were detected in seven of 39 (18%) COPD patients and associated with raised sputum neutrophil counts. IFN-β expression was raised when either picornavirus or PPM were detected (P=0.06), but no difference was seen regarding IL-29 or ISGs.Conclusion: ISGs expression was reduced in severe COPD that may favor exacerbation and contribute to disease progress by altering response to infection. Keywords: COPD, innate immunity, interferon-β, interferon-λ1, interferon-stimulated geneshttps://www.dovepress.com/reduced-sputum-expression-of-interferon-stimulated-genes-in-severe-cop-peer-reviewed-article-COPDCOPDInnate ImmunityInterferon-Interferon-1Interferon-stimulated genes.
spellingShingle Hilzendeger C
da Silva J
Henket M
Schleich F
Corhay JL
Kebadze T
Edwards MR
Mallia P
Johnston SL
Louis R
Reduced sputum expression of interferon-stimulated genes in severe COPD
International Journal of COPD
COPD
Innate Immunity
Interferon-
Interferon-1
Interferon-stimulated genes.
title Reduced sputum expression of interferon-stimulated genes in severe COPD
title_full Reduced sputum expression of interferon-stimulated genes in severe COPD
title_fullStr Reduced sputum expression of interferon-stimulated genes in severe COPD
title_full_unstemmed Reduced sputum expression of interferon-stimulated genes in severe COPD
title_short Reduced sputum expression of interferon-stimulated genes in severe COPD
title_sort reduced sputum expression of interferon stimulated genes in severe copd
topic COPD
Innate Immunity
Interferon-
Interferon-1
Interferon-stimulated genes.
url https://www.dovepress.com/reduced-sputum-expression-of-interferon-stimulated-genes-in-severe-cop-peer-reviewed-article-COPD
work_keys_str_mv AT hilzendegerc reducedsputumexpressionofinterferonstimulatedgenesinseverecopd
AT dasilvaj reducedsputumexpressionofinterferonstimulatedgenesinseverecopd
AT henketm reducedsputumexpressionofinterferonstimulatedgenesinseverecopd
AT schleichf reducedsputumexpressionofinterferonstimulatedgenesinseverecopd
AT corhayjl reducedsputumexpressionofinterferonstimulatedgenesinseverecopd
AT kebadzet reducedsputumexpressionofinterferonstimulatedgenesinseverecopd
AT edwardsmr reducedsputumexpressionofinterferonstimulatedgenesinseverecopd
AT malliap reducedsputumexpressionofinterferonstimulatedgenesinseverecopd
AT johnstonsl reducedsputumexpressionofinterferonstimulatedgenesinseverecopd
AT louisr reducedsputumexpressionofinterferonstimulatedgenesinseverecopd